Ottawa-Shanghai Joint School of Medicine


MA Jing


Tel: 15800983436

Research Interests: 胃肠功能与能量代谢的调控


Ma Jing, director of department of Endocrine and Metabolism in Renji Hospital, Shanghai JiaoTong University School of Medicine. She got her Ph.D from university of Adelaide, Australia in 2010 and act as a visiting scholar in Mayo clinic of USA in 2018. She is currently the committee member of the Endocrinology branch of Shanghai Medical Association and the Hepatology and editor member of Metabolism group of the Endocrinology branch of Chinese Medical Association. She is the vice editor of Frontier in Endocrinology and Metabolic Syndrome and Related Disorders.

Dr. Ma mainly engaged in medical care, teaching, and scientific researches of Endocrine and Metabolism,specializing in diagnosis and treatment of thyroid, parathyroid, and adrenal gland. She has undertaken projects of Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China, Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support and Shanghai Pujiang Program et al. She has published 44 papers in SCI indexed journals including Diabetes, Diabetes Care and Diabetologia, among which 36 were published as the first author or corresponding author.


  1. Zhang M, Chen J, Yang M, Qian C, Liu Y, Qi Y, Feng R, Yang M, Liu W, Ma J. Low Doses of Sucralose Alter Fecal Microbiota in High-Fat Diet-Induced Obese Rats. Front Nutr. 2021 Dec 28;8:787055. doi: 10.3389/fnut.2021.787055. PMID: 35028307; PMCID: PMC8751733.

  2. Yue J#, Xu H#, Zhou Y#, Liu W, Han X, Mao Q, Li S, Tam LS, Ma J*, Liu W*. Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study. Front Endocrinol (Lausanne). 2021 Jun 23;12:611526. doi: 10.3389/fendo.2021.611526. PMID: 34248834; PMCID: PMC8261125.

  3. Vedarethinam V#, Huang L#, Zhang MC#, Su HY, Hu HQ, Xia HP, Liu Y, Wu BR, Wan X, Shen J,  Liu W*, Ma J* (Corresponding author), and  Qian K*. Vanadium core-shell nanorods inspect metabolic changes of diabetic retinopathy. Adv. Funct. Mater. 2020, 30 (35) , 2002791.

  4. Yang M#,Shi FH#,Liu W#,Zhang MC, Feng RL,Qian C,Liu W,Ma J (Corresponding author). Dapagliflozin Modulates the Fecal Microbiota in a Type 2 Diabetic Rat Model Front Endocrinol (Lausanne). 2020 Nov 17;11:635.

  5. Qian C#, Qi Y#, Feng R, Yang M, Zhang MC, Liu W, Rayner CK*, Ma J *(Corresponding author). Sucralose can improve glucose tolerance and upregulate expression of sweet taste receptors and glucose transporters in an obese rat model. Eur J Nutr. 2020;10.1007/s00394-020-02375-1.

  6. Shi FH#, Li H#, Yue J, Jiang YH, Gu ZC*, Ma J (Corresponding author)*, Lin HW*. Clinical adverse events of high-dose versus low-dose sodium-glucose co-transporter 2 inhibitors in type 2 diabetes: a meta-analysis of 51 randomized clinical trials. J Clin Endocrinol Metab. 2020 Nov 1;105(11):dgaa586.

  7. Shi FH#, Shen L#, Pan MM#, Ma LL, Zhang C, Gu ZC, Ma J (Corresponding author), Li H. The Successful Rapid Adjustment of Blood Glucose in a Patient With Acute Coronary Syndrome, Renal Insufficiency, and Diabetes: A Case Report of Management Coordinated by Clinical Pharmacists and Clinicians. Front Pharmacol. 2020 May 21;11:756.

  8. Zhang M#, Feng R#, Yue J#, Qian C, Yang M, Liu W, Rayner CK, Ma J (Corresponding author). Effects of Metformin and Sitagliptin Monotherapy on Expression of Intestinal and Renal Sweet Taste Receptors and Glucose Transporters in a Rat Model of Type 2 Diabetes Horm Metab Res. 2020 May;52(5):329-335.

  9. Ma J, Wan X, Wu X. The Cost-Effectiveness of Lifestyle Interventions for Preventing Diabetes in a Health Resource-Limited Setting. J Diabetes Res. 2020 Apr;2020:7410797.

  10. Xue JH, Liu W, Shi FH, Zheng J*, Ma J *(Corresponding author. Pleural Effusion Due to Use of Pioglitazone: A Case Report. Metab Syndr Relat Disord. 2020 Apr;18(3):168-171.

  11. Jiang Y#, Wang L#, Shi F, Zhou H, Zheng J, Cai J, Yang S, Ma J *(Corresponding author), Liu W*. Insulin Autoimmune Syndrome After Exposure to Clopidogrel: A Case Report Endocr Metab Immune Disord Drug Targets. 2020;20(8):1355-1362.

  12. Zhang M#, Feng R#, Yang M, Qian C, Wang Z, Liu W*, Ma J *(Corresponding author). Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats. BMJ Open Diabetes Res Care. 2019 Sep 20;7(1):e000717.

  13. Shi FH#, Li H#, Shen L#, Zhang Z, Jiang YH, Hu YM, Liu XY, Gu ZC*, Ma J* (Corresponding author), Lin HW*. Appraisal of Non-Cardiovascular Safety for Sodium-Glucose Co-Transporter 2 Inhibitors: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Clinical Trials. Front Pharmacol. 2019 Sep 19;10:1066.

  14. Yang M#, Liu Y#, Wen CH, Wu BR, Wan X, Luan W, Shen J, Liu W, Ma J (Corresponding author). Association between spousal diabetes status and diabetic retinopathy in Chinese patients with type 2 diabetes. Diab Vasc Dis Res. 2019 Sep;16(5):474-477.

  15. Feng RL#, Qian C#, Liu LY, Liu QJ, Jin YQ, Li SX, Liu W, Rayner CK, Ma J (Corresponding author). Secretion of Gut Hormones and Expression of Sweet Taste Receptors and Glucose Transporters in a Rat Model of Obesity. Obes Facts. 2019.12:190–198.

  16. Xu H#; Zhou H#; Teng XY; Lin TC; Feng RL; Liu QJ; Qiu HY; Rayner CK, Ma J(Co-corresponding author), Liu W(corresponding author). Effect of Initial Intensive Insulin Therapy Followed by Sitagliptin on β Cell Function in Patients with New Onset Type 2 Diabetes. J Diabetes Metab. 2018. 9(9): 803.

  17. Wang S#, Deng Y#, Xie X#, Ma J#(Co-first author), Xu M, Zhao X, Gu W, Hong J, Wang W, Xu G, Ning G, Gu Y, Zhang Y. Plasma bile acid changes in type 2 diabetes correlated with insulin secretion in two-step hyperglycemic clamp J Diabetes.  2018 Nov;10(11):874-885.

  18. Ma J, Vella A. What Has Bariatric Surgery Taught Us About the Role of the Upper Gastrointestinal Tract in the Regulation of Postprandial Glucose Metabolism? Front Endocrinol (Lausanne). 2018 Jun;9:324.

  19. Wu B, Wan X, Ma J (Corresponding author). Cost-effectiveness of prevention and management of diabetic foot ulcer and amputation in a health resource-limited setting. J Diabetes. 2018 Apr;10(4):320-327.

  20. 20.Gu Y, Wang X, Li J, Zhang Y, Zhong H, Liu R, Zhang D, Feng Q, Xie X, Hong J, Ren H, Liu W, Ma J, Su Q, Zhang H, Yang J, Wang X, Zhao X, Gu W, Bi Y, Peng Y, Xu X, Xia H, Li F, Xu X, Yang H, Xu G, Madsen L, Kristiansen K, Ning G, Wang W. Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment. Nat Commun. 2017 Nov;8(1):1785. IF: 12.124

  21. 21.Feng RL#, Qian C#, Liu QJ, Jin YQ, Liu LY, Li SX, Zhou H, Liu W, Rayner CK, Ma J (Corresponding author). Expression of sweet taste receptor and gut hormone secretion in modelled type 2 diabetes. General and Comparative Endocrinology. 2017; 252:142-149.

  22. Li S#, Chu Q#, Ma J# (Co-first author), Sun Y, Tao T, Huang R, Liao Y, Yue J, Zheng J, Wang L, Xue X, Zhu M, Kang X, Yin H, Liu W. Discovery of novel lipid profiles in PCOS: Do insulin and androgen oppositely regulate bioactive lipid production? J Clin Endocrinol Metab, 2017 Mar, 102(3)5:810-821.

  23. Ma J#, Zhou H#, Xu H, Chen X, Teng XY, Liu QJ, Liu W. The initial assessment of daily insulin dose in Chinese newly diagnosed Type 2 Diabetes, J Diabetes Res, 2016, 2016:7245947.

  24. Ma J, Jesudason DR, Stevens JE, Keogh JB, Jones KL, Clifton PM, Horowitz M, Rayner CK, Sustained effects of a protein ‘preload’ on glycaemia and gastric emptying over 4 weeks in patients with type 2 diabetes: A randomized clinical trial, Diabetes Res Clin Pract, 2015 May,108(2):e31-4.

  25. Lin TC#, Li SX#, Xu H, Zhou H, Feng RL, Liu W, Sun Y, Ma J (Corresponding author). Gastrointestinal hormone secretion in women with polycystic ovary syndrome: an observational study. Human Reproduction, 2015, 30(11):2639–2644. 2015 Nov,30(11):2639-2644.

  26. Ma J, Lin TC, Liu W. Gastrointestinal hormones and polycystic ovary syndrome. Endocrine. 2014 May 4. Endocrine, 2014 Dec,47(3):668-78.

  27. Ma J, Liu LY, Wu PH, Liao Y, Tao T, Liu W. Comparison of metformin and repaglinide monotherapy in the treatment of new onset type 2 diabetes mellitus in China. J Diabetes Res, 2014, 2014: 294017.

  28. Ma J, Checklin HL, Wishart JM, Stevens JE, Jones KL, Horowitz M, Meyer JH,Rayner CK. A randomized trialofenteric-coated nutrient pellets to stimulate gastrointestinal peptide release and lower glycaemia in type 2 diabetes. Diabetologia, 2013 Jun,56(6):1236-42.

  29. Ma J, Pilichiewicz AN, Feinle-Bisset C, Wishart JM, Jones KL, Horowitz M, Rayner CK. Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes. Diabet Med, 2012 May,29(5):604-8.

  30. Ma J, Chang J, Checklin HL, Young RL, Jones KL, Horowitz M, Rayner CK. Effect of the artificial sweetener, sucralose, on small intestinal glucose absorption in healthy human subjects. Br J Nutr, 2010 Sep,104(6):803-6.

  31. Ma J, Bellon M, Wishart JM, Young RL, Jones KL, Horowitz M, Rayner CK. Effects of cefaclor on gastric emptying and cholecystokinin release in healthy humans. Regul Pept, 2010 Jan, 159(1-3):156-9.

  32. Ma J, Rayner CK, Jones KL, Horowitz M. Insulin secretion in healthy subjects and patients with Type 2 diabetes--role of the gastrointestinal tract. Best Pract Res Clin Endocrinol Metab, 2009 Aug, 23(4):413-24.

  33. Ma J, Stevens JE, Cukier K, Maddox AF, Wishart JM, Jones KL, Clifton PM,Horowitz M, Rayner CK. Effects of a protein ‘preload’ on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care, 2009 Sep, 32(9):1600-2.

  34. Ma J, Rayner CK, Jones KL, Horowitz M. Diabetic gastroparesis: diagnosis and management. Drugs, 2009 May, 29;69(8): 971-86.

  35. Ma J, Bellon M, Wishart JM, Young R, Blackshaw LA, Jones KL, Horowitz M, Rayner CK. Effect of the artificial sweetener, sucralose, on gastric emptying and incretin hormone release in healthy subject. Am J Physiol Gastrointest Liver Physiol, 2009 Apr, 296(4): G735-9.

  36. Ma J, Rayner CK,Jones KL, Horowitz M. Impact of gastroparesis on glycaemic control in diabetes. Diabetes management. 2009 March.

  37. Ma J, Ma Z, Wang J, Milne RW, Xu D, Davey AK, Evans AM. Isosteviol reduces plasma glucose levels in the intravenous glucose tolerance test in Zucker diabetic fatty rats. Diabetes Obes Metab. 2007 Jul;9(4):597-9.

  38. Cai J, Zhang Y, Wang Y, Li S, Wang L, Zheng J, Jiang Y, Dong Y, Zhou H, Hu Y, Ma J, Liu W, Tao T. High Thyroid Stimulating Hormone Level Is Associated With Hyperandrogenism in Euthyroid Polycystic Ovary Syndrome (PCOS) Women, Independent of Age, BMI, and Thyroid Autoimmunity: A Cross-Sectional Analysis. Front Endocrinol (Lausanne). 2019 Apr 10;10:222.

  39. Huang R, Zheng J, Li S, Tao T, Ma J, Liu W. Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome, Acta Obstet Gynecol Scand, 2015, 94(5):494-500.

  40. Wu T, Ma J, Bound MJ, Checklin H, Deacon CF, Jones KL, Horowitz M, Rayner CK. Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans, and patients with type 2 diabetes treated with or without metformin. Diabetes, 2014 Aug, 63(8):2776-87.

  41. Rayner CK, Ma J, Jones KL, Clifton PM, Horowitz M, Protein ‘pre-loads’ in type 2 diabetes: what do we know and what do we need to find out? Diabetologia, 2014 Dec, 57: 2603-2604.

  42. Young RL, Chia B, Isaacs NJ, Ma J, Khoo J, Wu T, Horowitz M, Rayner CK. Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetes. Diabetes, 2013 Oct, 62(10):3532-41.

  43. Yue J, Wang L, Huang R, Li S, Ma J, Teng X, Liu W. Dehydroepiandrosterone-sulfate (DHEAS) promotes MIN6 cells insulin secretion via inhibition of AMP-activated protein kinase. Biochem Biophys Res Commun, 2013 Nov, 440(4):756-61.

  44. Rayner CK, Ma J, Jones KL, Horowitz M. Comment on: Chen et al. Utilizing the second-meal effect in type 2 diabetes: practical use of a soya yogurt snack. Diabetes Care. 2011 May;34(5): e55.

  45. 张敏纯,麻静 (通讯作者)。人造甜味剂影响糖代谢的肠道机制。中华糖尿病杂志, 2018, 10(12):813-816

  46. 钱程, 冯日露,吴斌,麻静(通讯作者)。糖尿病大鼠肠道甜味受体表达及肠促胰素分泌的变化。中国医药导报, 2018, (17): 7-11

  47. 李志勇,刘宇,黄薇,凌小媛,麻静(通讯作者)。上海市浦江社区短病程2型糖尿病患者血糖控制影响因素分析。上海交通大学学报(医学版), 2018, (01): 89-94

  48. 冯日露,麻静(通讯作者)。糖尿病胃轻瘫的发病机制、诊断和治疗研究进展。上海交通大学学报(医学版),2016,36(5):761-76647

  49. 蒋毅弘,刘伟,周峘, 麻静(通讯作者). 糖尿病患者胃排空速率的临床观察[J]. 上海交通大学学报(医学版),2020,40(9):1249-1255. DOI:10.3969/j.issn.